Indication

Osteoporosis in male patient

Osteoporosis in male patients is a systemic metabolic bone disease characterized by compromised bone strength, low bone mineral density, and microarchitectural deterioration of skeletal tissue, which leads to heightened bone fragility and susceptibility to low-trauma fractures. Read more about Osteoporosis in male patient

63 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common Osteoporosis in male patient therapies.

Showing 19–27 of 63 drugs

Filter & compare in the drug finder →Opens the drug finder with Osteoporosis in male patient preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Osteoporosis in male patient.

Osteoporosis in male patients is a systemic metabolic bone disease characterized by compromised bone strength, low bone mineral density, and microarchitectural deterioration of skeletal tissue, which leads to heightened bone fragility and susceptibility to low-trauma fractures.

In men, the condition typically arises from age-related decreases in osteoblastic bone formation, progressive cortical thinning, and declining bioavailable sex steroids, though a substantial proportion of cases stem from secondary etiologies such as hypogonadism, prolonged glucocorticoid exposure, excessive alcohol intake, or androgen deprivation therapy.

Clinically, it is diagnosed by a low-trauma fragility fracture or a bone mineral density T-score of -2.5 or lower at the spine or hip, carrying significant morbidity and higher post-fracture mortality rates compared to female counterparts.

Personalize your experience

Follow Osteoporosis in male patient and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it